Pulse Biosciences (PLSE) Notes Payables (2021 - 2023)

Pulse Biosciences' Notes Payables history runs 3 years deep, the most recent figure standing at $801000.0 for Q1 2023.

• In Q1 2023, Notes Payables changed N/A year-over-year to $801000.0; the TTM figure through Mar 2023 stood at $801000.0 (changed N/A YoY), while the FY2022 annual figure was $917000.0, up 110.32% from the prior year.
• Notes Payables was $801000.0 for Q1 2023 at Pulse Biosciences, down from $917000.0 in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $1.7 million in Q2 2021 to a low of $98000.0 in Q3 2022.
• Historically, Notes Payables has averaged $740857.1 across 3 years, with a median of $801000.0 in 2023.
• Biggest YoY gain for Notes Payables was 110.32% in 2022; the steepest drop was 90.98% in 2022.
• A 3-year view of Notes Payables shows it stood at $436000.0 in 2021, then jumped by 110.32% to $917000.0 in 2022, then fell by 12.65% to $801000.0 in 2023.
• The last three Notes Payables figures came in at $801000.0 (Q1 2023), $917000.0 (Q4 2022), and $98000.0 (Q3 2022), per Business Quant data.